XTL Biopharmaceutica (Israel) Market Value
| XTLB Stock | ILS 4.80 0.40 7.69% |
| Symbol | XTL |
XTL Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XTL Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XTL Biopharmaceutica.
| 03/13/2023 |
| 03/02/2025 |
If you would invest 0.00 in XTL Biopharmaceutica on March 13, 2023 and sell it all today you would earn a total of 0.00 from holding XTL Biopharmaceuticals or generate 0.0% return on investment in XTL Biopharmaceutica over 720 days. XTL Biopharmaceutica is related to or competes with XTL Biopharmaceutica, Intercure, BioLine RX, Foresight Autonomous, and Bonus Biogroup. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical p... More
XTL Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XTL Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XTL Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 17.42 | |||
| Value At Risk | (5.36) | |||
| Potential Upside | 8.47 |
XTL Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XTL Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XTL Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use XTL Biopharmaceutica historical prices to predict the future XTL Biopharmaceutica's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | 3.65 |
XTL Biopharmaceuticals Backtested Returns
XTL Biopharmaceuticals shows Sharpe Ratio of -0.13, which attests that the company had a -0.13 % return per unit of standard deviation over the last 3 months. XTL Biopharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XTL Biopharmaceutica's Risk Adjusted Performance of (0.06), mean deviation of 2.94, and Standard Deviation of 3.9 to validate the risk estimate we provide. The firm maintains a market beta of -0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning XTL Biopharmaceutica are expected to decrease at a much lower rate. During the bear market, XTL Biopharmaceutica is likely to outperform the market. At this point, XTL Biopharmaceuticals has a negative expected return of -0.51%. Please make sure to check out XTL Biopharmaceutica's potential upside, kurtosis, and the relationship between the value at risk and skewness , to decide if XTL Biopharmaceuticals performance from the past will be repeated at some future point.
Auto-correlation | 0.18 |
Very weak predictability
XTL Biopharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between XTL Biopharmaceutica time series from 13th of March 2023 to 7th of March 2024 and 7th of March 2024 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XTL Biopharmaceuticals price movement. The serial correlation of 0.18 indicates that over 18.0% of current XTL Biopharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 3.94 |
XTL Biopharmaceuticals lagged returns against current returns
Autocorrelation, which is XTL Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XTL Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of XTL Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that XTL Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XTL Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XTL Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XTL Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XTL Biopharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
XTL Biopharmaceutica Lagged Returns
When evaluating XTL Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XTL Biopharmaceutica stock have on its future price. XTL Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XTL Biopharmaceutica autocorrelation shows the relationship between XTL Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in XTL Biopharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in XTL Stock
XTL Biopharmaceutica financial ratios help investors to determine whether XTL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTL with respect to the benefits of owning XTL Biopharmaceutica security.